Fisher Asset Management
DAWN

Fisher Asset Management’s Day One Biopharmaceuticals DAWN Stock Holding History

Fisher Asset Management’s Portfolio DAWN Stock Details DAWN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$937K Sell
43,698
-148,125
-77% -$2.09M ﹤0.01% 697
2025
Q4 		$1.79M Sell
191,823
-28,340
-13% -$237K ﹤0.01% 575
2025
Q3 		$1.55M Sell
220,163
-1,820
-0.8% -$12.5K ﹤0.01% 618
2025
Q2 		$1.44M Sell
221,983
-53,224
-19% -$366K ﹤0.01% 631
2025
Q1 		$2.18M Buy
275,207
+186,075
+209% +$2M ﹤0.01% 569
2024
Q4 		$1.13M Buy
89,132
+15,831
+22% +$220K ﹤0.01% 645
2024
Q3 		$1.02M Hold
73,301
– – ﹤0.01% 657
2024
Q2 		$1.01M Buy
73,301
+4,890
+7% +$71.5K ﹤0.01% 679
2024
Q1 		$1.13M Sell
68,411
-35
-0.1% -$524 ﹤0.01% 670
2023
Q4 		$999K Buy
68,446
+32,238
+89% +$391K ﹤0.01% 690
2023
Q3 		$444K Hold
36,208
– – ﹤0.01% 863
2023
Q2 		$432K Hold
36,208
– – ﹤0.01% 885
2023
Q1 		$484K Sell
36,208
-18
-0% -$352 ﹤0.01% 860
2022
Q4 		$780K Sell
36,226
-9,300
-20% -$191K ﹤0.01% 800
2022
Q3 		$912K Buy
+45,526
New +$968K ﹤0.01% 689

Other funds holding DAWN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
KC
Kryger Capital London, United Kingdom $1.41B AUM 86.31% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

Fisher Asset Management's DAWN Position: Q1 2026 in Review

Fisher Asset Management reduced its Day One Biopharmaceuticals (DAWN) stake by 77% in Q1 2026, selling an estimated $2.09M and leaving 43,698 shares worth $937K. The position accounts for ﹤0.01% of the portfolio, ranked #697.

Fisher Asset Management first reported a position in DAWN in Q3 2022 and has held it in 15 quarters since. The position peaked at $2.18M in Q1 2025. 206 funds tracked by Wall St. Rank hold DAWN as of Q1 2026.

  • Fisher Asset Management held 43,698 shares of Day One Biopharmaceuticals worth $937K as of Q1 2026.
  • Fisher Asset Management sold 148,125 Day One Biopharmaceuticals shares in Q1 2026, an estimated $2.09M.
  • Day One Biopharmaceuticals made up ﹤0.01% of Fisher Asset Management's portfolio in Q1 2026, its #697 holding.
  • Fisher Asset Management first reported a position in Day One Biopharmaceuticals in Q3 2022 and has held it in 15 quarters since.
  • Fisher Asset Management's Day One Biopharmaceuticals position peaked at $2.18M in Q1 2025.
  • 206 funds tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q1 2026.

Based on Fisher Asset Management's 13F filing for Q1 2026, filed 5 May 2026.